The Chemours Company EBITDA for the Trailing 12 Months (TTM) ending June 30, 2025: USD 237.00 M

The Chemours Company EBITDA is USD 237.00 M for the Trailing 12 Months (TTM) ending June 30, 2025, a -60.37% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • The Chemours Company EBITDA for the Trailing 12 Months (TTM) ending June 30, 2024 was USD 598.00 M, a 32.59% change year over year.
  • The Chemours Company EBITDA for the Trailing 12 Months (TTM) ending June 30, 2023 was USD 451.00 M, a -65.62% change year over year.
  • The Chemours Company EBITDA for the Trailing 12 Months (TTM) ending June 30, 2022 was USD 1.31 B, a 68.42% change year over year.
  • The Chemours Company EBITDA for the Trailing 12 Months (TTM) ending June 30, 2021 was USD 779.00 M, a 180.22% change year over year.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)